Prosecution Insights
Last updated: October 25, 2026

Gambro Lundia AB

Technology areas: Chemistry & Materials • Medical Devices & Mechanical Engineering

19 pending office actions • 11 art units • 17 examiners • 0 of 19 (0%) have an AI response strategy ready • 33 patents granted in the last 365 days

Analysis

Gambro Lundia AB has 19 pending office actions in Chemistry & Materials. The matters span 17 distinct examiners and 10 art units, reflecting a broad prosecution footprint across technical and examining teams.

PEO, JONATHAN M is the busiest examiner, with 2 pending actions. That limited concentration provides a possible point for tracking recurring issues, but most of the docket remains distributed across other examiners.

The portfolio calls for disciplined coordination of claim language, disclosure support, and response positions. Because the matters occupy many units, counsel should combine centralized portfolio standards with application-specific analysis of prior art, interviews, and amendment scope.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

19
Total Pending OAs
12
Non-Final OAs
6
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

8
Hard (42%)
7
Medium (37%)
4
Easy (21%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only3 (16%)
§101 + other1 (5%)
§103 only5 (26%)
§102 only1 (5%)
§112 only3 (16%)
Double-patenting only1 (5%)
Double-patenting + other1 (5%)
Multi-statute (no §101)4 (21%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

9
Life Sciences
47% of docket
1
Information Tech
5% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
8
Mechanical / Eng
42% of docket
1
Business / Other
5% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

190 h
Manual time on pending OAs
38 h
Time saved (low, 20%)
66 h
Time saved (mid, 35%)
1.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PEO, JONATHAN M 2 48.4% +47.6%
LE, QUYNH DAO 2 33.3% +12.1%
KONVES, ADRIANNA N 1 76.3% +14.7%
SHIBEROU, MAHELET 1 73.7% +26.2%
SPAMER, DONALD R 1 59.4% +32.3%
LUCCHESI, NICHOLAS D 1 78.4% +9.5%
KALIHER, HANS CHRISTIAN 1 62.9% +27.3%
MPAMUGO, CHINYERE 1 28.9% +26.9%
CHIU, TAK LIANG 1 45.5% +24.6%
BARSKY, JARED 1 50.3% +22.8%

Hard Cases (8)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18721129 MEDICAL DEVICE INTEROPERABILITY METHODS, APPARATUS, AND SYSTEM MPAMUGO, CHINYERE 26d overdue
18035052 APPARATUS FOR EXTRACORPOREAL TREATMENT OF BLOOD AND PROCESS OF CALCULATING SET FLOW RATES IN A MEDICAL APPARATUS FOR EXTRACORPOREAL TREATMENT OF BLOOD DAKKAK, JIHAD 10d overdue
17421757 MEMBRANE WITH IMMOBILIZED ANTICOAGULANT AND PROCESS FOR PRODUCING SAME ELLINGTON, MARRIAH C G 22d
18030116 ESTIMATING RESIDUAL RENAL FUNCTION NEWTON, CHAD A 29d
18711827 DIALYSIS FLUID COMPRISING KETONE BODIES FOR THE TREATMENT OF CANCER BARSKY, JARED —
18572121 ACIDIC AND ALKALINE CLEANING OF ION EXCHANGE SYSTEMS, SUCH AS WATER PURIFIERS, BY ION EXCHANGE RESIN FITZSIMMONS, ALLISON G —
17757266 FLUID DIVERTING DEVICE FOR AN APPARATUS FOR EXTRACORPOREAL TREATMENT OF BLOOD AND BLOOD SET PROVIDED WITH SAID FLUID DIVERTING DEVICE ARBLE, JESSICA R —
17635029 METHOD FOR PRIMING AN EXTRACORPOREAL BLOOD CIRCUIT OF AN APPARATUS FOR EXTRACORPOREAL TREATMENT OF BLOOD AND APPARATUS FOR EXTRACORPOREAL TREATMENT OF BLOOD LE, QUYNH DAO —

Interview Candidates (11)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18721129 MEDICAL DEVICE INTEROPERABILITY METHODS, APPARATUS, AND SYSTEM MPAMUGO, CHINYERE 26d overdue
19106504 DEVICE AND PROCESS FOR THE MANUFACTURE OF HOLLOW FIBER MEMBRANE BUNDLES KONVES, ADRIANNA N —
18974051 EXTRACORPOREAL BLOOD TREATMENT FLOW RATE ADJUSTMENT SHIBEROU, MAHELET —
18872148 DEVICE FOR DISINFECTING AND CLEANING A CATHETER, AND A METHOD THEREOF SPAMER, DONALD R —
18807339 DOPED MEMBRANES PEO, JONATHAN M —
18722260 APPARATUS FOR EXTRACORPOREAL BLOOD TREATMENT KALIHER, HANS CHRISTIAN —
18719692 PROCESS FOR MAKING A FILTRATION AND/OR DIFFUSION DEVICE CHIU, TAK LIANG —
18711827 DIALYSIS FLUID COMPRISING KETONE BODIES FOR THE TREATMENT OF CANCER BARSKY, JARED —

Top Art Units

Art UnitApps
3781 5
1773 3
1779 2
1748 1
2171 1
1799 1
3772 1
3685 1
1771 1
1628 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19106504 DEVICE AND PROCESS FOR THE MANUFACTURE OF HOLLOW FIBER MEMBRANE BUNDLES KONVES, ADRIANNA N 1748 §103 Non-Final OA — Pending Feb 25, 2025
18974051 EXTRACORPOREAL BLOOD TREATMENT FLOW RATE ADJUSTMENT SHIBEROU, MAHELET 2171 DP Non-Final OA — Pending Dec 09, 2024
18872148 DEVICE FOR DISINFECTING AND CLEANING A CATHETER, AND A METHOD THEREOF SPAMER, DONALD R 1799 §112 Non-Final OA — Pending Dec 05, 2024
18844270 GENERATING MEDICAL FLUID FOR RENAL REPLACEMENT THERAPY LUCCHESI, NICHOLAS D 3772 §112 Non-Final OA — Pending Sep 05, 2024
18807339 DOPED MEMBRANES PEO, JONATHAN M — §103 Non-Final OA — Pending Aug 16, 2024
18722260 APPARATUS FOR EXTRACORPOREAL BLOOD TREATMENT KALIHER, HANS CHRISTIAN 3781 §112 Non-Final OA — Pending Jun 20, 2024
18721129 MEDICAL DEVICE INTEROPERABILITY METHODS, APPARATUS, AND SYSTEM MPAMUGO, CHINYERE 3685 §101 Final Rejection 26d overdue Pending Jun 17, 2024
18719692 PROCESS FOR MAKING A FILTRATION AND/OR DIFFUSION DEVICE CHIU, TAK LIANG 1771 §103§112DP Non-Final OA — Pending Jun 13, 2024
18711827 DIALYSIS FLUID COMPRISING KETONE BODIES FOR THE TREATMENT OF CANCER BARSKY, JARED 1628 §101§103 Final Rejection — Pending May 20, 2024
18608304 PREPARING AN EXTRACORPOREAL BLOOD TREATMENT APPARATUS KURTZ, BENJAMIN M 1779 §102 Final Rejection — Pending Mar 18, 2024
18572121 ACIDIC AND ALKALINE CLEANING OF ION EXCHANGE SYSTEMS, SUCH AS WATER PURIFIERS, BY ION EXCHANGE RESIN FITZSIMMONS, ALLISON G 1773 §102§103§112 Non-Final OA — Pending Dec 19, 2023
18554418 APPARATUS AND METHODS FOR EFFICIENT PRODUCTION OF DIALYSIS FLUID USING FORWARD OSMOSIS MCGANN, BERNADETTE KAREN 1773 §103 Final Rejection — Pending Oct 06, 2023
18035052 APPARATUS FOR EXTRACORPOREAL TREATMENT OF BLOOD AND PROCESS OF CALCULATING SET FLOW RATES IN A MEDICAL APPARATUS FOR EXTRACORPOREAL TREATMENT OF BLOOD DAKKAK, JIHAD 3781 §101 Final Rejection 10d overdue Pending May 02, 2023
18030116 ESTIMATING RESIDUAL RENAL FUNCTION NEWTON, CHAD A 3681 §101 Non-Final OA 29d Pending Apr 04, 2023
18108091 PACKAGE FOR AN ACIDIC DIALYSIS FLUID CONCENTRATE CONTAINING CITRATE AND GLUCOSE PEO, JONATHAN M 1779 §103 Non-Final OA — Pending Feb 10, 2023
17757266 FLUID DIVERTING DEVICE FOR AN APPARATUS FOR EXTRACORPOREAL TREATMENT OF BLOOD AND BLOOD SET PROVIDED WITH SAID FLUID DIVERTING DEVICE ARBLE, JESSICA R 3781 §102§103§112 Non-Final OA — Pending Jun 13, 2022
17635029 METHOD FOR PRIMING AN EXTRACORPOREAL BLOOD CIRCUIT OF AN APPARATUS FOR EXTRACORPOREAL TREATMENT OF BLOOD AND APPARATUS FOR EXTRACORPOREAL TREATMENT OF BLOOD LE, QUYNH DAO 3781 §103§112 Non-Final OA — Pending Feb 14, 2022
17634855 NON-REMOVABLE CONNECTION SYSTEM LE, QUYNH DAO 3781 §103 Final Rejection — Pending Feb 11, 2022
17421757 MEMBRANE WITH IMMOBILIZED ANTICOAGULANT AND PROCESS FOR PRODUCING SAME ELLINGTON, MARRIAH C G 1773 §103§112 Non-Final OA 22d Pending Jul 09, 2021

Managing Gambro Lundia AB's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Gambro Lundia AB have?

Gambro Lundia AB has 19 pending office actions as of October 2026, spread across 11 art units and 17 examiners.

Which USPTO examiner handles the most Gambro Lundia AB applications?

Jonathan M Peo has the most, with 2 of Gambro Lundia AB's pending office actions.

What technology area are Gambro Lundia AB's patent applications in?

Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month